Formulation development and evaluation of nimesulide transdermal gel patch system

Abstract

The objective was to develop a reservoir-type nimesulide gel patch for controlled drug delivery and avoid the gastrointestinal adverse effects associated with the oral delivery of nimesulide. Six patch formulations of nimesulide gel comprising of 20–40% for ethanol and 20–40% for propylene glycol as permeation enhancers were constructed. Carbopol 934 was used as a gelling agent. The reservoir compartment of transdermal patch was filled with the gel. The in vitro release and skin permeation were assessed using USP apparatus V. The optimized formulation was obtained on the basis of the in vitro drug release and permeation results. The surface area of optimized formulation (F3) was reduced to 1 cm2, and permeation of drug was determined through Franz diffusion cell using Strat-M transdermal diffusional membrane. The nimesulide reservoir patch was placed in the donor compartment. The receptor compartment was filled with 5 mL of permeation medium [normal saline containing 20% v/v PEG-400 was used as dissolution media (pH 7.4)] stirred by magnetic stirrer. The skin sensitivity reaction of the optimized patch was evaluated by Draize method. The formulation F3 comprising of 40% ethyl alcohol and 20% propylene glycol was considered optimized due to maximum % of drug release (86.3 ± 2.73%) and permeation of (3048.84 ± 17.23 µg/cm2), having flux of 449.92 µg/cm2 h and lag time of 0.197 h with no visible skin sensitivity reaction. The study demonstrates that the reservoir-type transdermal patch of nimesulide gel has the potential of delivering drug across the skin in a controlled release manner.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. 1.

    Benson HA (2005) Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2(1):23–33

    CAS  Article  Google Scholar 

  2. 2.

    Kalluri H, Banga AK (2011) Transdermal delivery of proteins. Aaps Pharmscitech 12(1):431–441

    CAS  Article  Google Scholar 

  3. 3.

    Barry BW (2001) Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14(2):101–114

    CAS  Article  Google Scholar 

  4. 4.

    Saroha K, Singh S, Aggarwal A, Nanda S (2013) Transdermal gels—an alternative vehicle for drug delivery. Int J Pharm Chem Biol Sci 3(3):66

    Google Scholar 

  5. 5.

    Zhu Y, Lin L, Chen Y, Song Y, Lu W, Guo Y (2020) Extreme temperature-tolerant conductive gel with antibacterial activity for flexible dual-response sensors. ACS Appl Mater Interfaces 5:66

    Google Scholar 

  6. 6.

    Mariotti N, Bonomo M, Fagiolari L, Barbero N, Gerbaldi C, Bella F, Barolo C (2020) Recent advances in eco-friendly and cost-effective materials towards sustainable dye-sensitized solar cells. Green Chem 22(21):7168–7218

    CAS  Article  Google Scholar 

  7. 7.

    Galliano S, Bella F, Bonomo M, Viscardi G, Gerbaldi C, Boschloo G, Barolo C (2020) Hydrogel electrolytes based on xanthan gum: green route towards stable dye-sensitized solar cells. Nanomaterials 10(8):1585

    CAS  Article  Google Scholar 

  8. 8.

    Mali RA, Pattan SR, Seoin H, Nirmal SA, Vaykole AM, Shaikh A, Pattan S (2011) Preparation and evaluation of ibuprofen transdermal patch. Pharmacologyonline 1:623–627

    Google Scholar 

  9. 9.

    Rokhade AP, Shelke NB, Patil SA, Aminabhavi TM (2007) Novel interpenetrating polymer network microspheres of chitosan and methylcellulose for controlled release of theophylline. Carbohyd Polym 69(4):678–687. https://doi.org/10.1016/j.carbpol.2007.02.008

    CAS  Article  Google Scholar 

  10. 10.

    Rokhade AP, Shelke NB, Patil SA, Aminabhavi TM (2007) Novel hydrogel microspheres of chitosan and pluronic F-127 for controlled release of 5-fluorouracil. J Microencapsul 24(3):274–288. https://doi.org/10.1080/02652040701281365

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Jain S, Patel N, Madan P, Lin S (2016) Formulation and rheological evaluation of ethosome-loaded carbopol hydrogel for transdermal application. Drug Dev Ind Pharm 42(8):1315–1324

    CAS  Article  Google Scholar 

  12. 12.

    Ravikumara N, Madhusudhan B, Nagaraj T, Hiremat SR, Raina G (2009) Preparation and evaluation of nimesulide-loaded ethylcellulose and methylcellulose nanoparticles and microparticles for oral delivery. J Biomater Appl 24(1):47–64

    CAS  Article  Google Scholar 

  13. 13.

    Shahzad Y, Afreen U, Nisar Hussain Shah S, Hussain T (2013) Applying response surface methodology to optimize nimesulide permeation from topical formulation. Pharm Dev Technol 18(6):1391–1398

    CAS  Article  Google Scholar 

  14. 14.

    Seedher N, Bhatia S (2004) Surface activity of cox-2 inhibitors. Indian J Pharm Sci 66(2):254

    CAS  Google Scholar 

  15. 15.

    Güngör S, Bergişadi N (2004) Effect of penetration enhancers on in vitro percutaneous penetration of nimesulide through rat skin. Die Pharmazie-An Int J Pharm Sci 59(1):39–41

    Google Scholar 

  16. 16.

    Yoo JW, Moran B, Chen JS (2004) Stabilized conforming nodal integration in the natural-element method. Int J Numer Meth Eng 60(5):861–890

    Article  Google Scholar 

  17. 17.

    Kim S-R, Kim J-K, Park J-S, Kim C-K (2011) Dry elixir formulations of dexibuprofen for controlled release and enhanced oral bioavailability. Int J Pharm 404(1–2):301–307

    CAS  Article  Google Scholar 

  18. 18.

    Kim M-K, Zhao H, Lee C-H, Kim D-D (2001) Formulation of a reservoir-type testosterone transdermal delivery system. Int J Pharm 219(1–2):51–59

    CAS  Article  Google Scholar 

  19. 19.

    Pichayakorn W, Boonme P (2013) Evaluation of cross-linked chitosan microparticles containing metronidazole for periodontitis treatment. Mater Sci Eng C 33(3):1197–1202

    CAS  Article  Google Scholar 

  20. 20.

    Mukherjee B, Kanupriya MS, Das S, Patra B (2005) Sorbitan monolaurate 20 as a potential skin permeation enhancer in transdermal patches. J Appl Res 5(1):96–107

    CAS  Google Scholar 

  21. 21.

    Costa P, Lobo JMS (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13(2):123–133

    CAS  Article  Google Scholar 

  22. 22.

    Ali FR, Shoaib MH, Yousuf RI, Ali SA, Imtiaz MS, Bashir L (2017) Naz S (2017) Design, development, and optimization of dexibuprofen microemulsion based transdermal reservoir patches for controlled drug delivery. BioMed Res Int 5:66””

    Google Scholar 

  23. 23.

    Özgüney IS, Karasulu HY, Kantarci G, Sözer S, Güneri T, Ertan G (2006) Transdermal delivery of diclofenac sodium through rat skin from various formulations. AAPS PharmSciTech 7(4):E39–E45

    Article  Google Scholar 

  24. 24.

    Ubaidulla U, Reddy MV, Ruckmani K, Ahmad FJ, Khar RK (2007) Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech 8(1):E13–E20

    Article  Google Scholar 

  25. 25.

    Moser K, Kriwet K, Naik A, Kalia YN, Guy RH (2001) Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 52(2):103–112

    CAS  Article  Google Scholar 

  26. 26.

    Prodduturi S, Smith GJ, Wokovich AM, Doub WH, Westenberger BJ, Buhse L (2009) Reservoir based fentanyl transdermal drug delivery systems: effect of patch age on drug release and skin permeation. Pharm Res 26(6):1344–1352

    CAS  Article  Google Scholar 

  27. 27.

    Nonzioli A, Luque G, Fernandez C (1989) High performance liquid chromatographic method for the determination of nimesulide and its impurities. J High Resolut Chromatogr 12(6):413–416

    CAS  Article  Google Scholar 

  28. 28.

    Aggarwal G, Dhawan S, Harikumar S (2013) Formulation, in vitro, and in vivo evaluation of matrix-type transdermal patches containing olanzapine. Pharm Dev Technol 18(4):916–925

    CAS  Article  Google Scholar 

  29. 29.

    Seedher N, Kaur J (2003) Solubilization of nimesulide; use of co-solvents. Indian J Pharm Sci 65(1):58

    CAS  Google Scholar 

  30. 30.

    Bader S, Häusermann E, Monti T (2007) Nimesulide gel systems for topical use. Google Patents

  31. 31.

    Kumari A, Jain A, Hurkat P, Verma A, Jain SK (2016) Microsponges: a pioneering tool for biomedical applications. Crit Rev Therap Drug Carrier Syst 33(1):66

    Google Scholar 

  32. 32.

    Prausnitz MR, Mitragotri S, Langer R (2004) Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3(2):115–124

    CAS  Article  Google Scholar 

  33. 33.

    Giroux H, Perreault V, Britten M (2007) Characterization of hydrophobic flavor release profile in oil-in-water emulsions. J Food Sci 72(2):S125–S129

    CAS  Article  Google Scholar 

  34. 34.

    Costa P, Sousa Lobo J (2003) Evaluation of mathematical models describing drug release from estradiol transdermal systems. Drug Dev Ind Pharm 29(1):89–97

    CAS  Article  Google Scholar 

  35. 35.

    Hashmat D, Shoaib MH, Ali FR, Siddiqui F (2020) Lornoxicam controlled release transdermal gel patch: design, characterization and optimization using co-solvents as penetration enhancers. PLoS ONE 15(2):e0228908

    CAS  Article  Google Scholar 

  36. 36.

    Godin B, Touitou E (2007) Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 59(11):1152–1161

    CAS  Article  Google Scholar 

  37. 37.

    Dayal P, Kanikkannan N, Singh A, Singh M (2002) Comparison of the transdermal absorption of nimesulide from three commercially available gel formulations. Drug Dev Ind Pharm 28(3):297–304

    CAS  Article  Google Scholar 

  38. 38.

    Badran M, Shazly G, El-Badry M (2012) Effect of terpene liposomes on the transdermal delivery of hydrophobic model drug, nimesulide: characterization, stability and in vitro skin permeation. Afr J Pharm Pharmacol 6(43):3018–3026

    CAS  Article  Google Scholar 

  39. 39.

    Haq A, Goodyear B, Ameen D, Joshi V, Michniak-Kohn B (2018) Strat-M® synthetic membrane: Permeability comparison to human cadaver skin. Int J Pharm 547(1–2):432–437

    CAS  Article  Google Scholar 

  40. 40.

    Kalia YN, Guy RH (2001) Modeling transdermal drug release. Adv Drug Deliv Rev 48(2–3):159–172

    CAS  Article  Google Scholar 

  41. 41.

    Venkatraman S, Gale R (1998) Skin adhesives and skin adhesion: 1. Transdermal Drug Deliv Syst Biomater 19(13):1119–1136

    CAS  Google Scholar 

  42. 42.

    Draize JH, Woodard G, Calvery HO (1944) Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82(3):377–390

    CAS  Google Scholar 

Download references

Acknowledgements

The authors desire to show their gratitude to the Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, the University of Karachi, for laboratory facilities to conduct this study. This study was supported by the research grant funded by National Research Program for Universities (NRPU-6583) by Higher Education Commission Pakistan

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Muhammad Harris Shoaib or Rabia Ismail Yousuf.

Ethics declarations

Conflict of interest

The authors have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hassam, H., Shoaib, M.H., Yousuf, R.I. et al. Formulation development and evaluation of nimesulide transdermal gel patch system. Polym. Bull. (2021). https://doi.org/10.1007/s00289-021-03764-0

Download citation

Keywords

  • Nimesulide
  • Transdermal patch
  • USP dissolution apparatus V
  • Strat-M membrane
  • Drug release kinetics
  • Skin permeation